Lurasidone Sulfoxide :
(3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1-Oxido-1,2-benzisothiazol-3-yl)piperazin-1-yl methyl] cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione ; C28H36N4O3S ; MW: 508.68 ; |
Lurasidone 2-Epimer:
(3aR,4S,7R,7aS)-2-{(1R,2S)-2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-yl methyl] cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione hydrochloride ; CAS : 1318074-18-8 ; C28H37ClN4O2S ; MW: 529.14 ; |
Lurasidone Aminomethyl Impurity :
(1R,2R)-2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-yl methyl] cyclohexyl methylamine HCl ; C19H29ClN4S ; MW: 380.98 ; |
Lurasidone BI Piperazine Impurity :
1-(Benzo[d]isothiazol-3-yl)piperazine ; CAS : 87691-87-0 ; C11H13N3S ; MW: 219.31 ; |
Lurasidone DBI Piperazine Impurity :
1,4-Di(benzo[d]isothiazol-3-yl)piperazine ; CAS : 223586-82-1 ; C18H16N4S2 ; MW: 352.48 ; |
Lurasidone Enantiomer:
(3aR,4S,7R,7aS)-2-{(1S,2S)-2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-yl methyl] cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione hydrochloride ; CAS : 1448443-35-3 ; C28H37ClN4O2S ; MW: 529.14 ; |
Lurasidone HCl :
(3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-yl methyl] cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione hydrochloride ; CAS : 367514-88-3 ; C28H37ClN4O2S ; MW: 529.14 ; |
Lurasidone Open-Ring Acid (1R,2S,3R,4S)-Isomer :
(1R,2S,3R,4S)-3-((((1R,2R)-2-((4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl) methyl)cyclohexyl)methyl)carbamoyl)bicyclo[2.2.1]heptane-2-carboxylic acid ; C28H38N4O3S ; MW: 510.69 ; |
Lurasidone Sulfone :
(3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1,1-Dioxido-1,2-benzisothiazol-3-yl) piperazin-1-yl methyl] cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione ; CAS : 1644295-09-9 ; C28H36N4O4S ; MW: 524.67 ; |
LURASIDONE 1:
(1R,2R)-1,2-Cyclohexanedimethanol |
LURASIDONE 2:
(1R,2R)-1,2-Cyclohexanedimethanol 1,2-Dimethanesulfonate |